HT9402-26-Q-9404: Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement / Uniform Formulary Additional Discount Program

Notice ID:HT9402-26-Q-9404

The Department of War is required to maintain an integrated pharmacy benefits program for the Military Health System, including purchasing pharmaceutical agents and establishing a Uniform Formulary based on the P&T Committee’s review of clinical and cost effectiveness. Through the attached RFQ, industry quotes are sought for pharmaceutical agents in drug classes identified for potential Uniform Formulary placement, and the Defense Health Agency may award Uniform Formulary Blanket Purchase Agreements and Additional Discount Program Agreements based on the formulary decision. The P&T Committee will review specified newly approved drugs in November 2026, including products in oncology, antivirals, insulins, antibiotics, and other classes. A pre-quotation teleconference is scheduled for October 14, 2026, with details in the RFQ. Instructions and points of contact are provided in the RFQ.

DEPT OF DEFENSE DEFENSE HEALTH AGENCY (DHA) DEFENSE HEALTH AGENCY (DHA)

NAICS 325412 - Pharmaceutical Preparation Manufacturing

PSC 6505 DRUGS AND BIOLOGICALS

LOCATION: Not Given

Primary Contact

Tracy Banks

t****************v@health.mil

Not Given

Alt Contact

Kirk Heyen

k**************r@health.mil

Not Given

Links (1)

Title

Updated

Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement / Uniform Formulary Additional Discount Program

Links (1)

Attachments (16)